Dexcom is facing scrutiny and class-action lawsuits over alleged safety and accuracy issues with its G7 monitor.

Stifel concluded that DexCom represents its top investment choice within the diabetes market sector, leading to the Buy recommendation. In other recent news, DexCom has faced multiple developments ...

Thank you, operator, and welcome to DexCom's Third Quarter 2025 Earnings Call. Our agenda begins with Jake Leach, DexCom's President and Interim CEO, who will summarize our recent highlights and ...

Insulet ((PODD)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help ...

It can be difficult to wear an insulin pump or other diabetes device on your body. Use these tips to help manage your use of this technology and avoid any hiccups that might arise. Share on Pinterest ...

Wearable technology developer Biolinq has won FDA authorisation for a biosensor that can measure glucose levels continuously just beneath the skin's surface, without the need for a needle. The San ...

Oct 21 (Reuters) - Walmart (WMT.N), opens new tab will become the first U.S. retailer to sell Abbott Laboratories' (ABT.N), opens new tab over-the-counter continuous glucose monitor Lingo in physical ...

Senseonics Holdings stock has seen a dramatic shift in analyst sentiment. The consensus price target has surged from $1.43 to $28.60, reflecting growing optimism surrounding the company’s growth ...